Trial Profile
The Effect of Epogen and Venofer Dosing Management on Hemoglobin Stability
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 21 May 2014
Price :
$35
*
At a glance
- Drugs Epoetin alfa (Primary) ; Iron sucrose (Primary)
- Indications Anaemia
- Focus Therapeutic Use
- 25 Mar 2014 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
- 19 Nov 2013 New trial record